Literature DB >> 18684831

Retroviral nucleocapsid proteins display nonequivalent levels of nucleic acid chaperone activity.

Kristen M Stewart-Maynard1, Margareta Cruceanu, Fei Wang, My-Nuong Vo, Robert J Gorelick, Mark C Williams, Ioulia Rouzina, Karin Musier-Forsyth.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein (NC) is a nucleic acid chaperone that facilitates the remodeling of nucleic acids during various steps of the viral life cycle. Two main features of NC's chaperone activity are its abilities to aggregate and to destabilize nucleic acids. These functions are associated with NC's highly basic character and with its zinc finger domains, respectively. While the chaperone activity of HIV-1 NC has been extensively studied, less is known about the chaperone activities of other retroviral NCs. In this work, complementary experimental approaches were used to characterize and compare the chaperone activities of NC proteins from four different retroviruses: HIV-1, Moloney murine leukemia virus (MLV), Rous sarcoma virus (RSV), and human T-cell lymphotropic virus type 1 (HTLV-1). The different NCs exhibited significant differences in their overall chaperone activities, as demonstrated by gel shift annealing assays, decreasing in the order HIV-1 approximately RSV > MLV >> HTLV-1. In addition, whereas HIV-1, RSV, and MLV NCs are effective aggregating agents, HTLV-1 NC, which exhibits poor overall chaperone activity, is unable to aggregate nucleic acids. Measurements of equilibrium binding to single- and double-stranded oligonucleotides suggested that all four NC proteins have moderate duplex destabilization capabilities. Single-molecule DNA-stretching studies revealed striking differences in the kinetics of nucleic acid dissociation between the NC proteins, showing excellent correlation between nucleic acid dissociation kinetics and overall chaperone activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684831      PMCID: PMC2566285          DOI: 10.1128/JVI.01169-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  109 in total

1.  NMR structure of stem-loop SL2 of the HIV-1 psi RNA packaging signal reveals a novel A-U-A base-triple platform.

Authors:  G K Amarasinghe; R N De Guzman; R B Turner; M F Summers
Journal:  J Mol Biol       Date:  2000-05-26       Impact factor: 5.469

2.  Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides.

Authors:  R J Fisher; A Rein; M Fivash; M A Urbaneja; J R Casas-Finet; M Medaglia; L E Henderson
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

3.  Mapping of multiple RNA binding sites of human T-cell lymphotropic virus type I rex protein within 5'- and 3'-Rex response elements.

Authors:  P Askjaer; J Kjems
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

4.  Structure/function mapping of amino acids in the N-terminal zinc finger of the human immunodeficiency virus type 1 nucleocapsid protein: residues responsible for nucleic acid helix destabilizing activity.

Authors:  Nirupama Narayanan; Robert J Gorelick; Jeffrey J DeStefano
Journal:  Biochemistry       Date:  2006-10-17       Impact factor: 3.162

5.  DNA condensation by polyamines: a laser light scattering study of structural effects.

Authors:  V Vijayanathan; T Thomas; A Shirahata; T J Thomas
Journal:  Biochemistry       Date:  2001-11-13       Impact factor: 3.162

6.  HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro.

Authors:  Y X Feng; T D Copeland; L E Henderson; R J Gorelick; W J Bosche; J G Levin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

7.  Nucleic acid sequence discrimination by the HIV-1 nucleocapsid protein NCp7: a fluorescence study.

Authors:  C Vuilleumier; E Bombarda; N Morellet; D Gérard; B P Roques; Y Mély
Journal:  Biochemistry       Date:  1999-12-21       Impact factor: 3.162

8.  Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.

Authors:  W Fu; R J Gorelick; A Rein
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity.

Authors:  F Dib-Hajj; R Khan; D P Giedroc
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

10.  Mechanistic insights into the kinetics of HIV-1 nucleocapsid protein-facilitated tRNA annealing to the primer binding site.

Authors:  Michele R S Hargittai; Robert J Gorelick; Ioulia Rouzina; Karin Musier-Forsyth
Journal:  J Mol Biol       Date:  2004-04-02       Impact factor: 5.469

View more
  59 in total

Review 1.  Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Robert J Gorelick
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 2.  Single-molecule stretching studies of RNA chaperones.

Authors:  Hao Wu; Ioulia Rouzina; Mark C Williams
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 3.  Function of a retrotransposon nucleocapsid protein.

Authors:  Suzanne B Sandmeyer; Kristina A Clemens
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 4.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

5.  Single-molecule spectroscopic study of dynamic nanoscale DNA bending behavior of HIV-1 nucleocapsid protein.

Authors:  Hui Wang; Karin Musier-Forsyth; Caroline Falk; Paul F Barbara
Journal:  J Phys Chem B       Date:  2012-05-16       Impact factor: 2.991

6.  Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag.

Authors:  Jingga Inlora; Vineela Chukkapalli; David Derse; Akira Ono
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

7.  Human T-cell leukemia virus type 1 Gag domains have distinct RNA-binding specificities with implications for RNA packaging and dimerization.

Authors:  Weixin Wu; Joshua Hatterschide; Yu-Ci Syu; William A Cantara; Ruth J Blower; Heather M Hanson; Louis M Mansky; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

Review 8.  Nucleic acid chaperone properties of ORF1p from the non-LTR retrotransposon, LINE-1.

Authors:  Sandra L Martin
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

9.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

10.  Human T-cell lymphotropic virus type 1 nucleocapsid protein-induced structural changes in transactivation response DNA hairpin measured by single-molecule fluorescence resonance energy transfer.

Authors:  Qusai Darugar; Hannah Kim; Robert J Gorelick; Christy Landes
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.